Amendment and Mail Process Complete

LUPKYNIS

Aurinia Pharmaceuticals Inc.

Amendment and Mail Process Complete

Trademark Snap Shot Amendment & Mail Processing Stylesheet
(Table presents the data on Amendment & Mail Processing Complete)

OVERVIEW

SERIAL NUMBER 90306989 FILING DATE 11/09/2020
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY GARDNER, DAWNA BERYL
L.O. ASSIGNED 117

PUB INFORMATION

RUN DATE 08/25/2021
PUB DATE N/A
STATUS 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED
STATUS DATE 08/24/2021
LITERAL MARK ELEMENT LUPKYNIS

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) YES 1 (a) NO
1 (b) YES 1 (b) NO 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK NO
LITERAL MARK ELEMENT LUPKYNIS
MARK DRAWING CODE 3-AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/LETTER(S)/NUMBER(S)
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Aurinia Pharmaceuticals Inc.
ADDRESS 1203 - 4464 Markham St.
Victoria, B.C., V8Z7X8
ENTITY 11-COMPANY
CITIZENSHIP Canada

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Pharmaceutical preparations for the treatment of kidney disorders, lupus nephritis and focal segmental glomerulosclerosis

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE 01/22/2021 FIRST USE IN COMMERCE DATE 01/22/2021 CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO
DESCRIPTION OF MARK The mark consists of two lines or bands forming a design resembling a stylized arrow and the word LUPKYNIS in stylized form.

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
08/24/2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 019
08/24/2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 018
08/24/2021 ALIE A ASSIGNED TO LIE 017
08/20/2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 016
06/22/2021 AAUA E NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED 015
06/21/2021 IUAA P USE AMENDMENT ACCEPTED 014
06/21/2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 013
06/21/2021 GNRT O NON-FINAL ACTION E-MAILED 012
06/21/2021 CNRT R NON-FINAL ACTION WRITTEN 011
05/13/2021 AUPC I AMENDMENT TO USE PROCESSING COMPLETE 010
05/13/2021 IUAF S USE AMENDMENT FILED 009
05/12/2021 EAAU I TEAS AMENDMENT OF USE RECEIVED 008
02/24/2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED 007
02/24/2021 GNRT F NON-FINAL ACTION E-MAILED 006
02/24/2021 CNRT R NON-FINAL ACTION WRITTEN 005
02/19/2021 DOCK D ASSIGNED TO EXAMINER 004
01/08/2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED 003
01/07/2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
11/12/2020 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Matthew R. Wilmot
CORRESPONDENCE ADDRESS Matthew R. Wilmot
STOEL RIVES LLP
760 SW NINTH AVENUE, SUITE 3000
PORTLAND OR 97205
DOMESTIC REPRESENTATIVE NONE

Amendment and Mail Process Complete [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed